🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Elizabeth E. Ravenberg

The University of Texas MD Anderson Cancer Center

ORCID: 0009-0001-3972-1118
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6532592
Top 100%
0DataRank
Top 100%0 citations

Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qingqing Ding, Jason B. White +22 more

Papers

Driven by 12 papers — median percentile 0. Top paper: “Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer”.

Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0144
N/A
2.0DataRank · unranked
79 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3100
N/A
1.3DataRank · unranked
42 citations

Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qingqing Ding, Jason B. White +22 more

A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer

Radiology Imaging Cancer(2023)10.1148/rycan.230009
N/A
1.0DataRank · unranked
31 citations

Nabil Elshafeey, Aikaterini Kotrotsou, Huiqin Chen, Jong Bum Son, Medine Böge +21 more

Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy

Investigational New Drugs(2023)10.1007/s10637-023-01357-4
N/A
0.285DataRank · unranked
5 citations

Ryan Sun, Roland L. Bassett, Lei Huo, Jeffrey T. Chang, Mediget Teshome +24 more

Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer

npj Breast Cancer(2023)10.1038/s41523-022-00502-1
N/A
0DataRank · unranked
23 citations

Shirong Cai, Yizheng Tu, Jiansu Shao, Emily Powell, Abena B. Redwood +22 more

Data from Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530597
N/A
0DataRank · unranked
0 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Data from Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6532592
Top 100%
0DataRank
Top 100%0 citations

Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qingqing Ding, Jason B. White +22 more

A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer

Investigational New Drugs(2020)10.1007/s10637-020-00995-2
N/A
0DataRank · unranked
28 citations

Gaiane M. Rauch, Tanbin Rahman, Meghan Karuturi, Elizabeth E. Ravenberg, Jason B. White +14 more

Data from Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530597.v1
N/A
0DataRank · unranked
0 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

Academic Radiology(2021)10.1016/j.acra.2021.06.007
N/A
0DataRank · unranked
22 citations

David Spak, Gaiane M. Rauch, Lei Huo, Roland L. Bassett, Lumarie Santiago +14 more

Application of Artificial Intelligence to Plasma Metabolomics Profiles to Predict Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Frontiers in Artificial Intelligence(2022)10.3389/frai.2022.876100
N/A
0DataRank · unranked
21 citations

Ranran Wu, Jody V. Vykoukal, Eunice Murage, Rachelle Spencer, Jennifer B. Dennison +18 more

Mid-treatment Ultrasound Descriptors as Qualitative Imaging Biomarkers of Pathologic Complete Response in Patients with Triple-Negative Breast Cancer

Ultrasound in Medicine & Biology(2022)10.1016/j.ultrasmedbio.2022.01.018
N/A
0DataRank · unranked
5 citations

Beatriz E. Adrada, Deanna L. Lane, Gaiane M. Rauch, Stacy L. Moulder, Alastair M. Thompson +10 more